The development of “Top 5” lists across specialties and at regular intervals can help to remind physicians that optimal care is often possible at a lower cost. For purposes of cardiovascular risk reduction, generic statins, or their brand equivalents if priced similarly, remain the appropriate choice for dyslipidemic patients initiating statin therapy. In this article, we review the evidence supporting the choice of generic statins.
Green JB, Ross JS, Jackevicius CA, Shah ND, Krumholz HM. When Choosing Statin Therapy: The Case for Generics. JAMA Intern Med. 2013;173(3):229–232. doi:10.1001/jamainternmed.2013.1529
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: